Semaglutide (Ozempic) Approved for Type 2 Diabetes

WEDNESDAY, Dec. 6, 2017 — Ozempic (semaglutide) has been approved by the U.S. Food and Drug Administration as a weekly injection to treat type 2 diabetes in adults.
More than 28 million people in the United States have type 2 diabetes, which…
Source: Topamax